This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Clinical Trials
DWEK
Descemetorhexis for guttatae predominant Fuchs’ Endothelial Dystrophy: A prospective, interventional case series.
Overview
This study is investigating the DWEK surgical procedure – in which a small area of the diseased endothelium and Descemet’s membrane in the centre of the cornea are removed – in patients with Fuchs’ endothelial dystrophy, whose vision is degraded mainly by the build-up of the protein spots (‘guttatae’) on the endothelium, before the cornea has become significantly swollen.
The primary objective is to investigate whether the DWEK procedure will successfully allow for healthy endothelial cells from the untouched, outside areas of the cornea to regenerate and heal the central cornea in these patients.
For further information about this study please contact Cerulea on (03) 8638 5300 or email info@ceruleaclinicaltrials.org
- Principal Investigator
Associate Professor Elaine Chong and Dr Elsie Chan
This study is investigating the DWEK surgical procedure – in which a small area of the diseased endothelium and Descemet’s membrane in the centre of the cornea are removed – in patients with Fuchs’ endothelial dystrophy, whose vision is degraded mainly by the build-up of the protein spots (‘guttatae’) on the endothelium, before the cornea has become significantly swollen.
The primary objective is to investigate whether the DWEK procedure will successfully allow for healthy endothelial cells from the untouched, outside areas of the cornea to regenerate and heal the central cornea in these patients.
For further information about this study please contact Cerulea on (03) 8638 5300 or email info@ceruleaclinicaltrials.org
- Principal Investigator